This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (ACHIEVE-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05971940
Recruitment Status : Recruiting
First Posted : August 2, 2023
Last Update Posted : April 16, 2024
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 9, 2025
Estimated Study Completion Date : April 9, 2025